Biotech firm Bio-Techne beats quarterly estimates on strength in key unit [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
The Minneapolis, Minnesota-based company makes ?antibodies and enzymes, among other products, that are used in basic biology experiments. Its ?life sciences products and services are used in research, diagnostics and drug manufacturing worldwide. Life sciences companies are benefiting from improving conditions in the pharmaceutical market and easing policy uncertainty, helping offset continued weakness in academic spending. Bio-Techne delivered ?double-digit growth in its ?biggest end-market, large pharma, for the fourth consecutive quarter, CEO Kim Kelderman said in a statement. "That momentum, together ?with improving performance in biotech, continued stabilization among our U.S. academic customers, and ongoing growth in Asia, drove results that were largely in line with our expectations," ?Kelderman said. Shares of the company were up 2.1% in premarket trading. Peers ?Thermo Fisher Scientific and Danaher, had warned last month that cuts to U.S. academic research funding
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories [Yahoo! Finance]Yahoo! Finance
- Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical LaboratoriesPR Newswire
- Bio-Techne Announces Changes to its Leadership TeamPR Newswire
- Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.MarketBeat
TECH
Earnings
- 2/4/26 - Beat
TECH
Sec Filings
- 2/19/26 - Form 4
- 2/17/26 - Form 144
- 2/11/26 - Form 8-K
- TECH's page on the SEC website